| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5657329 | Clinical Gastroenterology and Hepatology | 2016 | 33 Pages |
Abstract
Based on a systematic review with meta-analysis, long-term use of PPIs (â¥12 months) is associated with an increased risk of FGPs. PPI therapy might also increase the risk of gastric cancer, but this association could be biased, because of the limited number of studies and possible confounding factors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
An Tran-Duy, Bart Spaetgens, Arno W. Hoes, Niek J. de Wit, Coen D.A. Stehouwer,